These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33626191)

  • 21. Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.
    Jalanko M; Tarkiainen M; Sipola P; Jääskeläinen P; Lauerma K; Laine M; Nieminen MS; Laakso M; Heliö T; Kuusisto J
    Ann Med; 2016 Sep; 48(6):417-427. PubMed ID: 27249556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Chan RH; Adler A; Care M; Chauhan V; Gollob MH; Ziv-Baran T; Fourey D; Hindieh W; Rakowski H; Spears DA
    Am J Cardiol; 2016 Oct; 118(8):1258-1263. PubMed ID: 27567133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship Between Obstructive Sleep Apnea and Late Gadolinium Enhancement and Their Effect on Cardiac Arrhythmias in Patients with Hypertrophic Obstructive Cardiomyopathy.
    Wang S; Cui H; Ji K; Zhu C; Huang X; Lai Y; Wang S
    Nat Sci Sleep; 2021; 13():447-456. PubMed ID: 33790677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias.
    Magnusson P; Mörner S
    J Cardiovasc Electrophysiol; 2021 Jan; 32(1):129-135. PubMed ID: 33108031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular twist in hypertrophic cardiomyopathy : Predictor of nonsustained ventricular tachycardia.
    Candan O; Gecmen C; Kalaycı A; Bayam E; Guner A; Gunduz S; Cersit S; Ozkan M
    Herz; 2019 May; 44(3):238-246. PubMed ID: 29038823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of Mitral Leaflet Elongation to Nonsustained Ventricular Tachycardia in Patients with Obstructive Hypertrophic Cardiomyopathy.
    Song C; Zhang Y; Zheng X; Lu J; Fang X; Wang S; Huang X
    Am J Cardiol; 2021 Nov; 158():112-117. PubMed ID: 34465462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
    Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: noninvasive evidence of electrical and textural substrate for ventricular arrhythmias.
    Limongelli G; Pacileo G; Cerrato F; Verrengia M; Di Simone A; Severino S; Sarubbi B; Calabrò R
    J Am Soc Echocardiogr; 2003 Aug; 16(8):803-7. PubMed ID: 12878988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
    Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy.
    Adduci C; Boldini F; Palano F; Musumeci B; De Lucia C; Russo D; Volpe M; Autore C; Francia P
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2093-2098. PubMed ID: 32437006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular arrhythmias and left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Piva e Mattos B; Torres MA; Freitas VC; Scolari FL; Loreto MS
    Arq Bras Cardiol; 2013 May; 100(5):452-9. PubMed ID: 23579622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kwapiszewska A; Kukula K; Jamiolkowski J; Dabrowski M; Derejko P; Oreziak A; Baranowski R; Spiewak M; Marczak M; Klisiewicz A; Szepietowska B; Chmielak Z; Witkowski A
    Clin Cardiol; 2018 Oct; 41(10):1336-1340. PubMed ID: 30120784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial QT Dispersion Predicts Nonsustained Ventricular Tachycardia and Correlates with Confined Systodiastolic Dysfunction in Hypertrophic Cardiomyopathy.
    Magrì D; Piccirillo G; Ricotta A; De Cecco CN; Mastromarino V; Serdoz A; Muscogiuri G; Gregori M; Casenghi M; Cauti FM; Oliviero G; Musumeci MB; Maruotti A; Autore C
    Cardiology; 2015; 131(2):122-9. PubMed ID: 25925893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined right and left ventricular mechanical dispersion enhance the arrhythmic risk stratification in hypertrophic cardiomyopathy.
    Popa-Fotea NM; Micheu MM; Onciul S; Zamfir D; Dorobanţu M
    J Cardiol; 2020 Oct; 76(4):364-370. PubMed ID: 32507507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.